A mathematical model for reconstitution of granulopoiesis after high dose chemotherapy with autologous stem cell transplantation

被引:32
|
作者
Ostby, I [1 ]
Rusten, LS
Kvalheim, G
Grottum, P
机构
[1] Univ Oslo, Dept Informat, N-0316 Oslo, Norway
[2] Norwegian Radium Hosp, Stem Cell Lab, N-0310 Oslo, Norway
关键词
granulopoiesis; mathematical model; high dose chemotherapy; stem cell support; engraftment time; CFU-GM cells; CD34+cells;
D O I
10.1007/s00285-003-0198-6
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
High dose chemotherapy supported with hematopoietic progenitor cells gives a characteristic neutropenic period (blood neutrophils <0.5.10(9) c/l) ranging from 10 to 16 days. The question of a correlation between the CFU-GM content of the transplanted CD34+ cells and time to neutrophil recovery by patients having been given high-dose chemotherapy (HD-CT) with stem cell support was addressed by means of a mathematical model of granulopoiesis. The model utilizes a convection-reaction partial differential equation (PDE) with feedback from a cytokine compartment on proliferation, maturation, and mobilization of granulocytes from bone marrow to blood. The observed number of CFU-GM cells in the transplanted CD34+ cell autograft was used as input to the model. Using this approach, the observed gross relationship between CFU-GM content in the reinfused blood product and engraftment time could be reproduced. At the same time, the effects of assumed physiological mechanisms, especially some of the effects of G-CSF on proliferation rate, maturation rate, mobilization, and cell death, could be investigated and discussed relative to observed engraftment. The model makes it possible to explain how cytokines interfere with progenitor cell mobilization from bone marrow to blood, and it points out the implications of a regulating mechanism for the granulocyte maturation rate.
引用
收藏
页码:101 / 136
页数:36
相关论文
共 50 条
  • [41] B-cells reconstitution after autologous stem cell transplantation
    Gartcheva, Lidia
    Mihova, Antoaneta
    Ganeva, Penka
    Guenova, Margarita
    Spassov, Branimir
    BONE MARROW TRANSPLANTATION, 2019, 54 : 281 - 282
  • [42] Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation
    Guillaume, T
    Rubinstein, DB
    Symann, M
    BLOOD, 1998, 92 (05) : 1471 - 1490
  • [43] Immune reconstitution after high dose therapy with autologous blood stem cell support.
    Steingrimsdottir, H
    Gruber, A
    Bjorkholm, M
    Svensson, A
    Hansson, M
    BONE MARROW TRANSPLANTATION, 1998, 21 : S130 - S130
  • [44] The Efficacy of High-Dose Chemotherapy and Autologous Stem Cell Transplantation for High-Risk Osteosarcoma
    Sakiyama, Hideki
    Hamada, Satoru
    Yagi, Takeshi
    Miyamoto, Jiro
    Oshiro, Tokiko
    Uehara, Taichi
    Kiyuna, Shinobu
    Tome, Yasunori
    Maehara, Hiroki
    Matsuda, Takehiro
    Higa, Takeshi
    Hyakuna, Nobuyuki
    Nakanishi, Koichi
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S60 - S60
  • [45] HIGH DOSE CHEMOTHERAPY WITH AMIFOSTINE CHEMOPROTECTION AND AUTOLOGOUS STEM CELL TRANSPLANTATION FOR HIGH RISK EWING SARCOMA
    Jodele, Sonata
    Davies, Stella M.
    Filipovich, Alexandra
    Bleesing, Jack. J.
    Mehta, Parinda A.
    Breneman, John C.
    Lavigne, Ruth
    Perentesis, John
    PEDIATRIC BLOOD & CANCER, 2009, 52 (06) : 701 - 701
  • [46] Autologous peripheral blood stem cell transplantation after high-dose chemotherapy with TBE in relapsing or refractory NHL
    Heussner, P
    Casper, J
    Petershofen, E
    Kleine, HD
    Metzner, B
    Junghanss, C
    Alscher, A
    Freund, M
    BONE MARROW TRANSPLANTATION, 1998, 22 : S17 - S17
  • [47] Treatment outcomes in multiple sclerosis patients after high-dose chemotherapy plus autologous stem cell transplantation
    Shevchenko, Y
    Novik, A
    Afanasiev, B
    Lisukov, I
    Ionova, T
    Kulagin, A
    Malysheva, O
    Bisaga, G
    Melnichenko, V
    Chelombit, L
    Voloshin, S
    Fedorenko, D
    Vereschagina, I
    Kishtovich, A
    Gorodokin, G
    MULTIPLE SCLEROSIS, 2005, 11 : S177 - S177
  • [48] Kinetics of peg-filgrastim after high-dose chemotherapy and autologous peripheral blood stem cell transplantation
    N Piccirillo
    S De Matteis
    S De Vita
    L Laurenti
    P Chiusolo
    F Sorà
    G Reddiconto
    G d'Onofrio
    G Leone
    S Sica
    Bone Marrow Transplantation, 2007, 40 : 579 - 583
  • [49] Early versus late administration of pegfilgrastim after high-dose chemotherapy and autologous hematopoietic stem cell transplantation
    Kahl, C.
    Sayer, H. G.
    Hinke, A.
    Freund, M.
    Casper, J.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2012, 138 (03) : 513 - 517
  • [50] Neutropenic enterocolitis after high-dose chemotherapy and autologous stem cell transplantation: incidence, risk factors, and outcome
    Gil, L.
    Poplawski, D.
    Mol, A.
    Nowicki, A.
    Schneider, A.
    Komarnicki, M.
    TRANSPLANT INFECTIOUS DISEASE, 2013, 15 (01) : 1 - 7